Sage Therapeutics Stock Soars 36% After Sale to Supernus Pharmaceuticals. What We Know.
Latest News
- Stock ETFs Up, Oil Down as Israel-Iran Fight Looks Contained
- Eli Lilly is making it cheaper and easier to buy high doses of blockbuster weight-loss drug Zepbound
- Mitsubishi in Talks to Sign $8 Billion Deal With Gas Producer Aethon
- Crypto Firm Tron, Led By ‘Top Fan’ of Trump, Is Going Public
- Health Care Roundup: Market Talk
- Stocks to Watch Recap: U.S. Steel, Kraft Heinz, Circle, Warner Bros.